drugset / Trial / NCT04504864

Summary

The purpose of this study is to investigate the safety and efficacy of low-dose (50mg) aspirin as a secondary prevention drug in patients with Non-Cardioembolic Ischemic Stroke accompanied by cerebral microbleeds.

Timeline

Start
2020-10-01
Primary completion
2022-02
Completion
2022-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 50 mg —
Subject Aspirin Small molecule 100 mg —

Indications